Product Code: ETC070079 | Publication Date: Aug 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The United Arab Emirates (UAE) biobanking market has been witnessing steady growth, driven by the increasing emphasis on precision medicine and biomedical research. Biobanks play a crucial role in collecting, storing, and managing biological samples, such as blood, tissues, and DNA, along with relevant patient data. In the UAE, as the healthcare sector focuses on advancing medical research and personalized healthcare, the demand for biobanking services has surged. The market`s growth is influenced by the UAE investments in healthcare infrastructure, research collaborations, and the adoption of advanced technologies in the life sciences.
The growth of the UAE biobanking market is propelled by several key drivers. Firstly, the rising prevalence of chronic diseases and genetic disorders has increased the need for comprehensive biological samples for research and disease profiling. Biobanks provide researchers and healthcare professionals with a valuable resource for understanding disease mechanisms and developing targeted therapies. Secondly, the UAE support for research and development initiatives and the establishment of research hubs and centers of excellence have encouraged the growth of biobanking infrastructure in the country.
Despite the positive market outlook, the UAE biobanking market faces certain challenges. One significant challenge is the need for stringent ethical and regulatory frameworks to ensure patient data privacy and sample handling standards. Biobanks must adhere to international guidelines and ethical considerations while maintaining data security and confidentiality. Additionally, building public awareness and trust in biobanking initiatives is essential to encourage voluntary participation and sample donation.
The Covid-19 pandemic, which emerged in 2020, had an impact on the UAE biobanking market. The pandemic led to an increased focus on medical research and understanding the virus`s behavior and impact on different populations. Biobanks played a critical role in collecting and preserving Covid-19 samples, contributing to the development of diagnostic tests, therapies, and vaccines. The pandemic also underscored the importance of preparedness and investments in healthcare infrastructure, including biobanking facilities.
The UAE biobanking market is experiencing significant growth, driven by an increasing focus on precision medicine and the need for comprehensive biological samples for medical research. Biobanks play a crucial role in storing and preserving biological specimens, enabling researchers to access valuable data for studying diseases, conducting clinical trials, and developing personalized treatments. Key players leading this dynamic market include renowned institutions such as the UAE University Biobank, Dubai Health Authority Biobank, and Abu Dhabi Stem Cell Center. These leading biobanks are actively collaborating with academic and healthcare institutions to establish large and diverse collections of biological samples, empowering groundbreaking research and medical advancements. Additionally, biobanking leaders like Thermo Fisher Scientific and Qiagen N.V. are contributing to the market`s expansion, offering cutting-edge biobanking solutions and expertise to support the region`s healthcare and research initiatives. With the UAE`s commitment to advancing medical science and personalized healthcare, the biobanking market is set to witness further growth, providing an invaluable resource for researchers and healthcare professionals alike.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Biobanking Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, 2020 & 2027F |
3.3 United Arab Emirates (UAE) Biobanking Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Biobanking Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Biobanking Market Revenues & Volume Share, By Type, 2020 & 2027F |
3.6 United Arab Emirates (UAE) Biobanking Market Revenues & Volume Share, By Applications, 2020 & 2027F |
3.7 United Arab Emirates (UAE) Biobanking Market Revenues & Volume Share, By Sample Type, 2020 & 2027F |
4 United Arab Emirates (UAE) Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 United Arab Emirates (UAE) Biobanking Market Trends |
6 United Arab Emirates (UAE) Biobanking Market, By Types |
6.1 United Arab Emirates (UAE) Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Type, 2018 - 2027F |
6.1.3 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Equipment, 2018 - 2027F |
6.1.4 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Consumables, 2018 - 2027F |
6.1.5 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Services, 2018 - 2027F |
6.1.6 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Software, 2018 - 2027F |
6.2 United Arab Emirates (UAE) Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Regenerative Medicine, 2018 - 2027F |
6.2.3 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Life Science Research, 2018 - 2027F |
6.2.4 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Clinical Research, 2018 - 2027F |
6.3 United Arab Emirates (UAE) Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Blood Products, 2018 - 2027F |
6.3.3 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Human Tissues, 2018 - 2027F |
6.3.4 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Nucleic Acids, 2018 - 2027F |
6.3.5 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Cell Lines, 2018 - 2027F |
6.3.6 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Biological Fluids, 2018 - 2027F |
6.3.7 United Arab Emirates (UAE) Biobanking Market Revenues & Volume, By Human Waste Products, 2018 - 2027F |
7 United Arab Emirates (UAE) Biobanking Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Biobanking Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Biobanking Market Imports from Major Countries |
8 United Arab Emirates (UAE) Biobanking Market Key Performance Indicators |
9 United Arab Emirates (UAE) Biobanking Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Biobanking Market Opportunity Assessment, By Type, 2020 & 2027F |
9.2 United Arab Emirates (UAE) Biobanking Market Opportunity Assessment, By Applications, 2020 & 2027F |
9.3 United Arab Emirates (UAE) Biobanking Market Opportunity Assessment, By Sample Type, 2020 & 2027F |
10 United Arab Emirates (UAE) Biobanking Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Biobanking Market Revenue Share, By Companies, 2020 |
10.2 United Arab Emirates (UAE) Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |